Constitutional rearrangement of the architectural factor HMGA2:: A novel human phenotype including overgrowth and lipomas

被引:105
作者
Ligon, AH
Moore, SDP
Parisi, MA
Mealiffe, ME
Harris, DJ
Ferguson, HL
Quade, BJ
Morton, CC
机构
[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
[3] Childrens Hosp, Div Genet, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Childrens Hosp & Reg Med Ctr, Div Genet & Dev Med, Seattle, WA USA
[6] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA
关键词
D O I
10.1086/427565
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Although somatic mutations in a number of genes have been associated with development of human tumors, such as lipomas, relatively few examples exist of germline mutations in these genes. Here we describe an 8-year-old boy who has a de novo pericentric inversion of chromosome 12, with breakpoints at p11.22 and q14.3, and a phenotype including extreme somatic overgrowth, advanced endochondral bone and dental ages, a cerebellar tumor, and multiple lipomas. His chromosomal inversion was found to truncate HMGA2, a gene that encodes an architectural factor involved in the etiology of many benign mesenchymal tumors and that maps to the 12q14.3 breakpoint. Similar truncations of murine Hmga2 in transgenic mice result in somatic overgrowth and, in particular, increased abundance of fat and lipomas, features strikingly similar to those observed in the child. This represents the first report of a constitutional rearrangement affecting HMGA2 and demonstrates the role of this gene in human growth and development. Systematic genetic analysis and clinical studies of this child may offer unique insights into the role of HMGA2 in adipogenesis, osteogenesis, and general growth control.
引用
收藏
页码:340 / 348
页数:9
相关论文
共 38 条
  • [1] In vivo modulation of Hmgic reduces obesity
    Anand, A
    Chada, K
    [J]. NATURE GENETICS, 2000, 24 (04) : 377 - 380
  • [2] Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia
    Andrieux, J
    Demory, JL
    Dupriez, B
    Quief, S
    Plantier, I
    Roumier, C
    Bauters, F
    Laï, JL
    Kerckaert, JP
    [J]. GENES CHROMOSOMES & CANCER, 2004, 39 (01) : 82 - 87
  • [3] Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas
    Arlotta, P
    Tai, AKF
    Manfioletti, G
    Clifford, C
    Jay, G
    Ono, SJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) : 14394 - 14400
  • [4] HMGA2 is expressed in an allele-specific manner in human lipomas
    Ashar, HR
    Tkachenko, A
    Shah, P
    Chada, K
    [J]. CANCER GENETICS AND CYTOGENETICS, 2003, 143 (02) : 160 - 168
  • [5] ASHAR HR, 1995, CELL, V82, P57
  • [6] Battista S, 1999, CANCER RES, V59, P4793
  • [7] The tumor-associated gene HMGIC is expressed in normal and osteoarthritis-affected synovia
    Broberg, K
    Tallini, G
    Höglund, M
    Lindstrand, A
    Toksvig-Larsen, S
    Mertens, F
    [J]. MODERN PATHOLOGY, 2001, 14 (04) : 311 - 317
  • [8] Broberg K, 1999, GENE CHROMOSOME CANC, V24, P278
  • [9] CYTOGENETIC SUBTYPING OF 220 SALIVARY-GLAND PLEOMORPHIC ADENOMAS - CORRELATION TO OCCURRENCE, HISTOLOGICAL SUBTYPE, AND INVITRO CELLULAR BEHAVIOR
    BULLERDIEK, J
    WOBST, G
    MEYERBOLTE, K
    CHILLA, R
    HAUBRICH, J
    THODE, B
    BARTNITZKE, S
    [J]. CANCER GENETICS AND CYTOGENETICS, 1993, 65 (01) : 27 - 31
  • [10] Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas
    Dahlén, A
    Mertens, F
    Rydholm, A
    Brosjö, O
    Wejde, J
    Mandahl, N
    Panagopoulos, I
    [J]. MODERN PATHOLOGY, 2003, 16 (11) : 1132 - 1140